Cargando…
Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
In most oral cancer patients, surgical treatment includes resection of the primary tumor combined with excision of lymph nodes (LNs), either for staging or for treatment. All LNs harvested during surgery require tissue processing and subsequent microscopic histopathologic assessment to determine the...
Autores principales: | Vonk, Jasper, de Wit, Jaron G., Voskuil, Floris J., Tang, Yang Hang, Hooghiemstra, Wouter T.R., Linssen, Matthijs D., van den Broek, Evert, Doff, Jan J., de Visscher, Sebastiaan A.H.J., Schepman, Kees-Pieter, van der Vegt, Bert, van Dam, Gooitzen M., Witjes, Max J.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Nuclear Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051590/ https://www.ncbi.nlm.nih.gov/pubmed/34531264 http://dx.doi.org/10.2967/jnumed.121.262530 |
Ejemplares similares
-
Fluorescence molecular imaging using cetuximab‐800CW in cutaneous squamous cell carcinoma surgery: a proof‐of‐concept study
por: Vonk, Jasper, et al.
Publicado: (2022) -
EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
por: de Wit, Jaron G., et al.
Publicado: (2023) -
A Standardized Framework for Fluorescence-Guided Margin Assessment for Head and Neck Cancer Using a Tumor Acidosis Sensitive Optical Imaging Agent
por: Steinkamp, Pieter Jan, et al.
Publicado: (2021) -
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study
por: Voskuil, Floris Jan, et al.
Publicado: (2020) -
Improving oral cavity cancer diagnosis and treatment with fluorescence molecular imaging
por: Vonk, Jasper, et al.
Publicado: (2020)